Biotage AB, a Swedish pharmaceutical company, offers innovative separation technology and solutions for analytical and organic chemistry across various industries. With a low risk ESG score of 18.7, Biotage AB caters to a wide range of customers, including pharmaceutical, biotech, diagnostic, and academic laboratories, as well as organizations focused on sustainability and environmental protection. Operating in the Americas, APAC, and EMEA regions, Biotage AB's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.